First-line use of Pfizer’s Bosulif cleared in the US

21st December 2017 Uncategorised 0

Pfizer’s Bosulif has been approved in the US to treat patients with newly-diagnosed Ph+ chronic myelogenous leukemia.

More: First-line use of Pfizer’s Bosulif cleared in the US
Source: News